We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-2.75%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.1B
AUM Growth
+$273M
Cap. Flow
-$650M
Cap. Flow %
-4.61%
Top 10 Hldgs %
32.88%
Holding
703
New
–
Increased
221
Reduced
319
Closed
43

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$41.6M
2
NVDA icon
NVIDIA
NVDA
+$36M
3
ISRG icon
Intuitive Surgical
ISRG
+$33.8M
4
AMAT icon
Applied Materials
AMAT
+$32.4M
5
XP icon
XP
XP
+$31M

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$57.8M
2
JNJ icon
Johnson & Johnson
JNJ
+$54.9M
3
DHR icon
Danaher
DHR
+$41.9M
4
MSFT icon
Microsoft
MSFT
+$40.7M
5
LRCX icon
Lam Research
LRCX
+$37.4M

Sector Composition

Rank Sector Weight
1 Healthcare 26.08%
2 Technology 25.64%
3 Financials 11.81%
4 Industrials 7.9%
5 Materials 7.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TECK icon
1
Teck Resources
TECK
$27.8B
$879M 6.23%
11,301
-6,097
-35% -$253K
MSFT icon
2
Microsoft
MSFT
$2.95T
$723M 5.13%
2,290,874
-123,145
-5% -$40.7M
XP icon
3
XP
XP
$8.71B
$641M 4.54%
1,256,344
+1,236,344
+6,182% +$31M
AAPL icon
4
Apple
AAPL
$4.81T
$587M 4.16%
3,429,642
-83,321
-2% -$15.3M
GOOGL icon
5
Alphabet (Google) Class A
GOOGL
$4.24T
$387M 2.74%
2,955,357
-16,779
-0.6% -$2.17M
ZTO icon
6
ZTO Express
ZTO
$18.4B
$357M 2.53%
1,475,110
+3,000
+0.2% +$76.3K
MRK icon
7
Merck
MRK
$312B
$343M 2.43%
3,335,599
+209,628
+7% +$22.6M
NVDA icon
8
NVIDIA
NVDA
$5.02T
$252M 1.79%
5,800,960
+802,510
+16% +$36M
REGN icon
9
Regeneron Pharmaceuticals
REGN
$70.5B
$239M 1.69%
290,310
-15,308
-5% -$12M
AMGN icon
10
Amgen
AMGN
$198B
$232M 1.64%
861,737
+166,615
+24% +$41.6M
TMO icon
11
Thermo Fisher Scientific
TMO
$195B
$232M 1.64%
457,412
-8,595
-2% -$4.58M
LLY icon
12
Eli Lilly
LLY
$1.05T
$170M 1.2%
316,063
-23,254
-7% -$12M
PG icon
13
Procter & Gamble
PG
$345B
$166M 1.18%
1,140,869
+15,443
+1% +$2.36M
AMZN icon
14
Amazon
AMZN
$2.66T
$138M 0.98%
1,082,457
-80,908
-7% -$10.8M
DHR icon
15
Danaher
DHR
$127B
$135M 0.96%
694,163
-187,976
-21% -$41.9M
VRTX icon
16
Vertex Pharmaceuticals
VRTX
$122B
$134M 0.95%
384,331
-12,231
-3% -$4.28M
GOOG icon
17
Alphabet (Google) Class C
GOOG
$4.22T
$127M 0.9%
965,173
-55,494
-5% -$7.22M
ADBE icon
18
Adobe
ADBE
$90.3B
$127M 0.9%
248,520
-16,048
-6% -$8.42M
MA icon
19
Mastercard
MA
$476B
$123M 0.87%
309,488
-5,380
-2% -$2.16M
GILD icon
20
Gilead Sciences
GILD
$165B
$113M 0.8%
1,507,856
-173,939
-10% -$13.4M
SGEN
21
DELISTED
Seagen Inc. Common Stock
SGEN
$112M 0.8%
530,228
+449
+0.1% +$89.7K
NOW icon
22
ServiceNow
NOW
$105B
$109M 0.77%
971,445
+49,185
+5% +$5.61M
V icon
23
Visa
V
$677B
$108M 0.77%
471,279
-240,311
-34% -$57.8M
PANW icon
24
Palo Alto Networks
PANW
$279B
$104M 0.74%
886,348
+42,074
+5% +$4.98M
ISRG icon
25
Intuitive Surgical
ISRG
$124B
$98M 0.69%
335,326
+108,332
+48% +$33.8M
1
2 3 4 5

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q3 2023 Portfolio in Review

As of Q3 2023, Candriam SCA held 703 positions worth $14.1B, up 2% from $13.8B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Candriam SCA withdrew a net $650M in Q3 2023, closing 43 positions and reducing 319 holdings. Its most notable exit was Chinook Therapeutics, Inc. Common Stock, an estimated $31.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 31% a quarter earlier, followed by Technology and Financials.

Against the trend, Candriam SCA added an estimated $41.6M to Amgen.

  • Candriam SCA added most to Amgen in Q3 2023, an estimated $41.6M increase.
  • Candriam SCA's biggest Q3 2023 reduction was Visa, cutting an estimated $57.8M.
  • Candriam SCA fully exited Chinook Therapeutics, Inc. Common Stock in Q3 2023, selling an estimated $31.7M.
  • Candriam SCA's ten largest holdings make up 33% of its $14.1B portfolio in Q3 2023.
  • Candriam SCA opened 0 new positions and closed 43 in Q3 2023.
  • Candriam SCA's portfolio value rose 2% quarter-over-quarter to $14.1B.

Based on Candriam SCA's 13F filing for Q3 2023, filed 13 Nov 2023.